## Background: Tamoxifen commonly is used as adjuvant therapy for all stages of breast carcinoma. however, several studies have suggested an association between the use of tamoxifen in breast carcinoma patients and the subsequent development of endometrial carcinoma. the objective of this study was
Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma
β Scribed by Jagavkar, RS ;Shakespeare, TP ;Stevens, MJ
- Book ID
- 108931885
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 489 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0004-8461
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Sequential tamoxifen/exemestane therapy reportedly improves diseaseβfree survival in women with primary breast cancer compared with continued tamoxifen therapy. The objective of the current study was to assess the costβeffectiveness of switching to exemestane after 2 to
## BACKGROUND. The use of adjuvant tamoxifen to treat postmenopausal breast carcinoma patients as an adjunct to primary surgery is well established. The current study reports the long term results for a low risk stratum in a randomized trial of adjuvant tamoxifen. The main focus of this analysis w